Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D07UQQ
|
|||
| Former ID |
DNCL003417
|
|||
| Drug Name |
ACE-536
|
|||
| Indication | Myelodysplastic syndrome [ICD-11: 2A37; ICD-9: 238.7] | Phase 3 | [1] | |
| Anemia [ICD-11: 3A00-3A9Z; ICD-9: 280-285] | Phase 2 | [2] | ||
| Myelofibrosis [ICD-11: 2A20.2; ICD-10: D47.4] | Phase 2 | [1] | ||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA) | |||
| REF 2 | ClinicalTrials.gov (NCT02268409) ACE-536 Extension Study - Beta Thalassemia. U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.